There is provided a pharmaceutical composition that is adapted for pulmonaryadministration by inhalation, whichcomposition comprises a glitazone, such as pioglitazone or rosiglitazone, andone or more pharmaceutically acceptable carriersand/or excipients, and wherein the glitazone content of the compositionconsists of at least 95% by weight of the 5R enantiomerand less than 5% by weight of the 5S enantiomer. There is also provided a useand a kit.
